Journal of Biological Science and Education
Vol 3, No 1 (2021): June

Lentiviral shRNA Construction in Gene Therapy for Knock Down CYPIA1, and YWHAZ gene in Lung Cancer

Henik Anjayati (Institut Teknologi Bandung)



Article Info

Publish Date
31 Dec 2021

Abstract

Lung cancer is a disease that is in the top 10 causes of death globally. It is caused by CYP1A1 and YWHAZ genes expressed in the lungs. One of the solutions offered for lung cancer sufferers is gene therapy. Gene therapy for lung cancer is focused on the knock-down of expressed CYP1A1 and YWHAZ genes. It can be using shRNA transfected into lung cells by lentivirus. The lentivirus envelope is modified using glycoprotein filovirus, one of which is ebolavirus. Lentivirus pseudotyping can recognize certain cells. Especially, Ebolavirus can recognize lung cells. The lentiviral gene is designed to carry the gene of interest (shRNA) but no the infectious gene. The shRNA gene transfused into lung cancer cells will recognize and complement the specific target mRNA sites of the CYP1A1 and YWHAZ genes. After that, shRNA will cut the mRNA which should be expressed into a cancer protein. Unexpressed mRNA into protein causes cancer cell growth inhibited. Thus, this gene therapy solution is expected to be able to reduce the rate of death caused by lung cancer. Keywords: Lung cancer, CYP1A1 and YWHAZ genes, gene therapy, lentiviral, shRNA

Copyrights © 2021






Journal Info

Abbrev

biology

Publisher

Subject

Biochemistry, Genetics & Molecular Biology Education

Description

The journal receives research, review, report manuscripts on biology, environment, and education. The paper focus on biology study, curriculum, instruction, and assessment on biology, as well as biology teacher training and education, which are highly invited to be submitted in this ...